Antonio Moreno-Herrera

Antonio Moreno-Herrera

Auto-generated profile, based on publicly available information

Antonio Moreno-Herrera

Early Chemical Development, Pharmaceutical Sciences AstraZeneca Macclesfield UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2017 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDPeter W. Dettmar
Peter W. Dettmar
DGDiana Gil-Gonzalez
Diana Gil-Gonzalez
JFJeanine Fisher
Jeanine Fisher
LFLucy Flint
Lucy Flint
DRDaniel Rainforth
Daniel Rainforth
MPMark Potts
Mark Potts
Objective: Research to measure the chemical characterization of alginate rafts for good raft performance and ascertain how formulation can affect chemical parameters. Significance: A selection of alginate formulations was investigated all claiming to be proficient raft formers with significance between products established and ranked. Methods: Procedures were selected which demonstrated the chemical characterization allowing rafts to effectively impede the reflux into the esophagus or in severe cases to be refluxed preferentially into the esophagus and exert a demulcent effect, with focus of current research on methods which complement previous studies centered on physical properties. The alginate content was analyzed by a newly developed HPLC method. Methods were used to determine the neutralization profile and the acid neutralization within the raft determined along with how raft structure affects neutralization. Results: Alginate content of Gaviscon Double Action (GDA) within the raft was significantly superior (p < .0001) to all competitor products. The two products with the highest raft acid neutralization capacity were GDA and Rennie Duo, the latter product not being a raft former. Raft structure was key and GDA had the right level of porosity to allow for longer duration of neutralization. Conclusion: Alginate formulations require three chemical reactions to take place simultaneously: transformation to alginic acid, sodium carbonate reacting to form carbon dioxide, calcium releasing free calcium ions to bind with alginic acid providing strength to raft formation. GDA was significantly superior (p <.0001) to all other comparators.

1 April 2022 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LVLenci K. Vázquez-Jiménez
Lenci K. Vázquez-Jiménez
AMAntonio Moreno-Herrera
Antonio Moreno-Herrera
Alfredo Juárez-SaldivarAlfredo Juárez-Saldivar
Alfredo Juárez-Saldivar
AGAlonzo Gonzalez-Gonzalez
Alonzo Gonzalez-Gonzalez
EOEyra Ortiz-Pérez
Eyra Ortiz-Pérez
Gildardo RiveraGildardo Rivera
Gildardo Rivera
Background: Parasitic diseases caused by protozoa, such as Chagas disease, leishmaniasis, malaria, African trypanosomiasis, amoebiasis, trichomoniasis, and giardiasis, are considered serious public health problems in developing countries. Drug resistance among parasites justifies the search for new therapeutic drugs, and the identification of new targets becomes a valuable approach. In this scenario, the glycolysis pathway, which converts glucose into pyruvate, plays an important role in the protozoa energy supply, and it is therefore considered a promising target. In this pathway, triose phosphate isomerase (TIM) plays an essential role in efficient energy production. Furthermore, protozoa TIM shows structural differences with human enzyme counterparts, suggesting the possibility of obtaining selective inhibitors. Therefore, TIM is considered a valid approach to develop new antiprotozoal agents, inhibiting the glycolysis in the parasite. Objective: In this review, we discuss the drug design strategies, structure-activity relationship, and binding modes of outstanding TIM inhibitors against Trypanosoma cruzi, Trypanosoma brucei, Plasmodium falciparum, Giardia lamblia, Leishmania mexicana, Trichomonas vaginalis, and Entamoeba histolytica. Results: TIM inhibitors have mainly shown aromatic systems and symmetrical structure, where the size and type of heteroatom are important for enzyme inhibition. This inhibition is mainly based on the interaction with i) the interfacial region of TIM inducing changes on the quaternary and tertiary structure or ii) with the TIM catalytic region, the main pathways that disable the catalytic activity of the enzyme. Conclusion: Benzothiazole, benzoxazole, benzimidazole, and sulfhydryl derivatives stand out as TIM inhibitors. In silico and in vitro studies have demonstrated that the inhibitors bind mainly at the TIM dimer interface. In this review, the development of new TIM inhibitors as antiprotozoal drugs is demonstrated as an important pharmaceutical strategy that may lead to new therapies for these ancient parasitic diseases.

8 January 2018 in Frontiers in Endocrinology
Verified
Journal Article
Open access
JPJérémy Pasquier
Jérémy Pasquier
ALAnne-Gaëlle Lafont
Anne-Gaëlle Lafont
FDFlorian Denis
Florian Denis
BLBenjamin Lefranc
Benjamin Lefranc
CDChristophe Dubessy
Christophe Dubessy
KRKarine Rousseau
Karine Rousseau
The European eel (Anguilla anguilla) presents a blockade of sexual maturation at a prepubertal stage due to a deficient production of gonadotropins. We previously initiated, in the eel, the investigation of the kisspeptin system, one of the major gatekeepers of puberty in mammals, and we predicted the sequence of two Kiss genes. In the present study, we cloned and sequenced Kiss1 and Kiss2 cDNAs from the eel brain. The tissue distributions of Kiss1 and Kiss2 transcripts, as investigated by quantitative real-time PCR, showed that both genes are primarily expressed in the eel brain and pituitary. The two 10-residue long sequences characteristic of kisspeptin, eel Kp1(10) and Kp2(10), as well as two longer sequences, predicted as mature peptides, eel Kp1(15) and Kp2(12), were synthesized and functionally analyzed. Using rat Kiss1 receptor-transfected Chinese hamster ovary cells, we found that the four synthesized eel peptides were able to induce [Ca2+]i responses, indicating their ability to bind mammalian KissR-1 and to activate second messenger pathways. In primary culture of eel pituitary cells, all four peptides were able to specifically and dose-dependently inhibit lhβ expression, without any effect on fshβ, confirming our previous data with heterologous kisspeptins. Furthermore, in this eel in vitro system, all four peptides inhibited the expression of the type 2 GnRH receptor (gnrh-r2). Our data revealed a dual inhibitory effect of homologous kisspeptins on both pituitary lhβ and gnrh-r2 expression in the European eel.

1 November 2012 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
JCJose Cordoba-Chacon
Jose Cordoba-Chacon
Manuel D. GaheteManuel D. Gahete
Manuel D. Gahete
APAna I. Pozo-Salas
Ana I. Pozo-Salas
AMAntonio Moreno-Herrera
Antonio Moreno-Herrera
Justo CastañoJusto Castaño
Justo Castaño
Raul LuqueRaul Luque
Raul Luque
It has been suggested that adult metabolic dysfunction may be more severe in individuals who become obese as children compared with those who become obese later in life. To determine whether adult metabolic function differs if diet-induced weight gain occurs during the peripubertal age vs. if excess weight gain occurs after puberty, male C57Bl/6J mice were fed a low-fat (LF; 10% kcal from fat) or high-fat (HF; 60% kcal from fat) diet starting during the peripubertal period (pHF; 4 wk of age) or as adults (aHF; 12 wk of age). Both pHF and aHF mice were hyperinsulinemic and hyperglycemic, and both showed impaired glucose tolerance and insulin resistance compared with their LF-fed controls. However, despite a longer time on diet, pHF mice were relatively more insulin sensitive than aHF mice, which was associated with higher lean mass and circulating IGF-I levels. In addition, HF feeding had an overall stimulatory effect on circulating corticosterone levels; however, this rise was associated only with elevated plasma ACTH in the aHF mice. Despite the belief that adult metabolic dysfunction may be more severe in individuals who become obese as children, data generated using a diet-induced obese mouse model suggest that adult metabolic dysfunction associated with peripubertal onset of obesity is not worse than that associated with adult-onset obesity.

1 March 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AMAntonio Moreno-Herrera
Antonio Moreno-Herrera
SCSandra Cortez-Maya
Sandra Cortez-Maya
VBVirgilio Bocanegra‐García
Virgilio Bocanegra‐García
BBBimal Banik
Bimal Banik
Gildardo RiveraGildardo Rivera
Gildardo Rivera
Infections caused by Trypanosoma brucei, Trypanosoma cruzi, Leishmania spp., Entamoeba histolytica, Giardia lamblia, Plasmodium spp., and Trichomonas vaginalis, are part of a large list of human parasitic diseases. Together, they cause more than 500 million infections per year. These protozoa parasites affect both low- and high-income countries and their pharmacological treatments are limited. Therefore, new and more effective drugs in preclinical development could improve overall therapy for parasitic infections even when their mechanisms of action are unknown. In this review, a number of heterocyclic compounds (diamidine, guanidine, quinoline, benzimidazole, thiazole, diazanaphthalene, and their derivatives) reported as antiprotozoal agents are discussed as options for developing new pharmacological treatments for parasitic diseases.

20 February 2017 in Journal of Drug Targeting
Verified
Journal Article
Closed access
MKMuhammad Kashif
Muhammad Kashif
AMAntonio Moreno-Herrera
Antonio Moreno-Herrera
ELEdgar E. Lara-Ramírez
Edgar E. Lara-Ramírez
EREsther Ramírez-Moreno
Esther Ramírez-Moreno
VBVirgilio Bocanegra-García
Virgilio Bocanegra-García
Gildardo RiveraGildardo Rivera
Gildardo Rivera
Chagas is a lethal chronic disease that currently affects 8–10 million people worldwide, primarily in South and Central America. Trypanosoma cruzi trans-sialidase is an enzyme that is of vital importance for the survival of the parasite due to its key role in the transfer of sialic acid from the host to the parasite surface and it also helps the parasite combat the host’s immune system. This enzyme has no equivalent human enzyme; thus, it has become an interesting target for the development of inhibitors that combat the parasite. In this review, we summarize three classes of inhibitors (acceptor, donor and unrelated) with their inhibition values and their mode of action against this enzyme. Based on molecular docking, molecular dynamics and structure-activity relationship studies, it has been discovered that the molecules with –NH2, –OH and –COOH groups on an aromatic ring could be used as a scaffold for the development of new and potent trans-sialidase inhibitors due to their key interaction with active enzyme sites. In particular, carboxylic acid derivatives have importance over the sugar moiety due to their ease of synthesis and unique structure-activity relationship.